Drug Shortage Report for SODIUM CHLORIDE INJECTION, USP
| Report ID | 179693 |
| Drug Identification Number | 02139510 |
| Brand name | SODIUM CHLORIDE INJECTION, USP |
| Common or Proper name | SODIUM CHLORIDE INJECTION, USP |
| Company Name | FRESENIUS KABI CANADA LTD |
| Market Status | MARKETED |
| Active Ingredient(s) | SODIUM CHLORIDE |
| Strength(s) | 234MG |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRAVENOUS INTRAVENOUS |
| Packaging size | 200 mL |
| ATC code | B05XA |
| ATC description | I.V. SOLUTION ADDITIVES |
| Reason for shortage | Delay in shipping of the drug. |
| Anticipated start date | |
| Actual start date | 2023-01-01 |
| Estimated end date | 2023-01-20 |
| Actual end date | 2023-01-20 |
| Shortage status | Resolved |
| Updated date | 2023-01-26 |
| Company comments | Fresenius Kabi Canada regrets to advise that due to a shipping delay, we will be encountering a supply interruption on our Sodium Chloride Injection, USP 4 mmol/mL PBP Vial 200 mL effective January 1, 2023, until January 20,2023. |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 165 GALAXY BLVD, SUITE 100 TORONTO, ONTARIO CANADA M9W 0C8 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v4 | 2023-01-26 | French | Compare |
| v3 | 2023-01-26 | English | Compare |
| v2 | 2023-01-02 | French | Compare |
| v1 | 2023-01-02 | English | Compare |
Showing 1 to 4 of 4